Strategies such as depleting MDSCs, reprogramming TAMs to a pro-inflammatory state, and enhancing the activation of CD8+ T cells can create a more favorable immune landscape that promotes effective anti-tumor responses 77,78. This evidence concerns the gene CD8A and neoplasm.